Advanced Enzyme Technologies Ltd (ADVENZYMES) is currently trading at 293.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Advanced Enzyme Technologies Limited is the largest Indian enzyme company, specializing in manufacturing and selling enzyme-based solutions across various industries such as human health care, animal nutrition, and food processing. For the third quarter of FY26, the company's revenue grew by 2% year-on-year, showcasing stability despite challenging market conditions. In FY26, the animal nutrition segment performed exceptionally well, increasing revenues by 26% on a year-to-date basis, highlighting its growth potential within the company. The company's strategic acquisitions, including an increased stake in JC Biotech and SciTech Specialities, are aimed at enhancing its biotechnology capabilities and product offerings. Advanced Enzyme Technologies continues to emphasize innovation through significant R&D efforts and has launched new products, including in the human and animal nutrition sectors, indicating its commitment to growth and market expansion.

Over the past 52 weeks, Advanced Enzyme Technologies Ltd has traded between a low of ₹251.90 and a high of ₹419.80. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Advanced Enzyme Technologies Ltd has a market capitalization of approximately 3,326.25. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Advanced Enzyme Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.37 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 3,326.25 Cr, Advanced Enzyme Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Advanced Enzyme Technologies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Advanced Enzyme Technologies Ltd is 19.37. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Revenue from operations was INR 1,898 million in Q1 FY27, up 2% year-on-year from INR 1,859 million.

The company approved a share buyback with an aggregate amount not exceeding ₹69.70 crore.

The company reported net profit of ₹37 crore and revenue of ₹190 crore for Q1 FY27, as stated in the announced highlights.

The update cited revenue of ₹190 crore and net profit of ₹37 crore for the quarter. The consolidated table reported revenue from operations of ₹189.79 crore and net profit of ₹38.59 crore.